BOL

Ebola virus disease (EVD)or Ebola haemorrhagic fever is a severe and often deadly illness in humans, caused by the Ebola virus. The disease has high mortality rate, killing upto 90% of people who are infected.

Applications are invited from suitable candidates for filling up the purely temporary position of one Senior Research Fellow in DST’s Indo-Australian Joint project (with ICRISAT) entitled “Genomic Approach for Stress Tolerant Chickpea” under the...

www.ncbi.nlm.nih.gov - Sequence - Evolution - Function is an introduction to the computational approaches that play a critical role in the emerging new branch of biology known as functional genomics. The book provides the reader with an understanding of the...

Walk-In Interview for one position of Junior Research Fellow (JRF) in a SERB, Department of Science and Technology (DST) funded research project entitled “Design and evaluation of novel Beta-3 adrenoreceptor agonists for potential antidepressant...

The mission of our lab is to develop and apply new technologies and methods for genetics, genomics and molecular biology. Most of our work exploits next-generation DNA sequencing which is effectively emerging as a broadly enabling microscope for the...

One profile of Computational/Systems Biology and Machine Learning at Postdoc level is needed at the Laboratory of Immunobiology of Neurological Disorders led by Cinthia Farina, Institute of Experimental Neurology, Ospedale San Raffaele, Milano. The...

INSTITUTE OF ADVANCED STUDY IN SCIENCE AND TECHNOLOGY (An Autonomous Institute under Department of Science and Technology, Govt. of India) Paschim Boragaon, Garchuk, Guwahati-781035 Appointment Adv.No.2 Applications in plain paper are...

https://www.ga4gh.org/ - The Global Alliance for Genomics and Health (GA4GH) is a policy-framing and technical standards-setting organization, seeking to enable responsible genomic data sharing within a human rights framework. GA4GH core funders and sponsors enable our...

A new optogenetic protein gives neuroscientists more control over brain circuits.

The new SARS-CoV-2 version, B.1.1.7, which was first seen in the third week of September in Kent and Greater London, has since spread to other locations in the UK.